BIOMEX at the ASGCT 2025!
BIOMEX is excited to announce our first-ever presence at the ASGCT Annual Meeting – the American Society of Gene & Cell Therapy – taking place from May 13–17, 2025 in New Orleans, LA! Meet our experts Hannah Hill and Adrien Lecocq at Booth #1255 and discover how BIOMEX can support your work in Cell and Read More
CACLP 2025: Thank You for the Great Exchange!
We would like to extend our sincere thanks to all customers and interested visitors for the engaging conversations and valuable exchange during CACLP 2025, held from March 22 to 24. It was a pleasure to reconnect with familiar faces and to welcome new contacts at our booth. Throughout the event, we had numerous promising discussions, Read More
BIOMEX study team becomes IVD TRIALS GmbH!
Until December 31, 2024, the BIOMEX study team was an integral part of BIOMEX, delivering exceptional clinical IVD study services. As of January 1, 2025, our team transitioned to an independent company. It now operates under the name IVD TRIALS GmbH – allowing for greater flexibility, a stronger market position, and even more tailored services. Read More
Welcome to BIOMEX, Thomas Matthes!
We are excited to introduce Thomas Matthes as the new Director of the Life Sciences Business Unit at BIOMEX. With over 30 years of experience in the biotechnology, pharmaceutical, and diagnostics industries, he brings in-depth expertise in cell culture, stem cells, and personalized medicine. Thomas became aware of BIOMEX through LinkedIn, and the vision for Read More
Save the Date! Meet BIOMEX at CACLP 2025
We are excited to announce that BIOMEX will once again be part of CACLP 2025 in China! Are you looking for expert guidance on European IVDR requirements, support with regulatory validation studies, or high-quality biospecimens from a specialized German supplier? Our team is here to help. Where to find us? Visit us at Hall 7, Read More
End of the Year Wrap-Up 2024
As 2024 comes to an end, we take a moment to reflect on the milestones and achievements that marked this year, all while staying true to our mission of EmpoweringScientists. Here’s a look at the highlights: 20 Years of BIOMEX This year, we proudly celebrated 20 years of BIOMEX under the responsibility of Oliver Bosnjak. Read More
BIOMEX at MEDICA 2024
This year, BIOMEX was proud to participate in MEDICA 2024, the world’s leading trade fair for the medical industry. MEDICA has become an annual tradition for us, offering new opportunities every year to connect with customers, make valuable contacts and exchange ideas with industry professionals. As always, the highlight of the event was the opportunity Read More
BIOMEX at the Festival of Biologics 2024
This year, BIOMEX proudly attended the Festival of Biologics in Basel, one of the leading events in the field of biologics. Our colleague Dr. Manish Kumar represented BIOMEX at the congress, which brought together global experts, innovators and decision-makers to discuss the future of biologics and biotechnology. The Festival of Biologics is one of the Read More
149 days of syphilis progression captured in one panel!
We are excited to announce the launch of our Syphilis Seroconversion Panel. It is an important tool for improving the sensitivity of serological tests and is therefore very useful for the early diagnosis of syphilis. 𝐖𝐡𝐲 𝐭𝐡𝐢𝐬 𝐦𝐚𝐭𝐭𝐞𝐫𝐬 𝐟𝐨𝐫 𝐲𝐨𝐮𝐫 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬 Global syphilis resurgence: The number of syphilis cases is increasing worldwide, necessitating accurate diagnosis Read More
Genetic Mutations at BIOMEX
Unlock the Next Breakthrough in Cancer Therapy with Genetic Mutations at BIOMEX, we are leading the way in precision medicine, leveraging advanced genetic testing to drive the discovery and development of tailored therapies. Our repository, comprising over 3,000,000 FFPE blocks, coupled with our validated mass spectrometry-based system, enables faster detection of up to 96 mutations Read More
